Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1998 May;62(5):1044–1051. doi: 10.1086/301825

A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

N M van der Put 1, F Gabreëls 1, E M Stevens 1, J A Smeitink 1, F J Trijbels 1, T K Eskes 1, L P van den Heuvel 1, H J Blom 1
PMCID: PMC1377082  PMID: 9545395

Abstract

Recently, we showed that homozygosity for the common 677(C-->T) mutation in the methylenetetrahydrofolate reductase (MTHFR) gene, causing thermolability of the enzyme, is a risk factor for neural-tube defects (NTDs). We now report on another mutation in the same gene, the 1298(A-->C) mutation, which changes a glutamate into an alanine residue. This mutation destroys an MboII recognition site and has an allele frequency of .33. This 1298(A-->C) mutation results in decreased MTHFR activity (one-way analysis of variance [ANOVA] P < .0001), which is more pronounced in the homozygous than heterozygous state. Neither the homozygous nor the heterozygous state is associated with higher plasma homocysteine (Hcy) or a lower plasma folate concentration-phenomena that are evident with homozygosity for the 677(C-->T) mutation. However, there appears to be an interaction between these two common mutations. When compared with heterozygosity for either the 677(C-->T) or 1298(A-->C) mutations, the combined heterozygosity for the 1298(A-->C) and 677(C-->T) mutations was associated with reduced MTHFR specific activity (ANOVA P < .0001), higher Hcy, and decreased plasma folate levels (ANOVA P <.03). Thus, combined heterozygosity for both MTHFR mutations results in similar features as observed in homozygotes for the 677(C-->T) mutation. This combined heterozygosity was observed in 28% (n =86) of the NTD patients compared with 20% (n =403) among controls, resulting in an odds ratio of 2.04 (95% confidence interval: .9-4.7). These data suggest that the combined heterozygosity for the two MTHFR common mutations accounts for a proportion of folate-related NTDs, which is not explained by homozygosity for the 677(C-->T) mutation, and can be an additional genetic risk factor for NTDs.

Full Text

The Full Text of this article is available as a PDF (650.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Copp A. J., Brook F. A., Estibeiro J. P., Shum A. S., Cockroft D. L. The embryonic development of mammalian neural tube defects. Prog Neurobiol. 1990;35(5):363–403. doi: 10.1016/0301-0082(90)90037-h. [DOI] [PubMed] [Google Scholar]
  2. Czeizel A. E., Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992 Dec 24;327(26):1832–1835. doi: 10.1056/NEJM199212243272602. [DOI] [PubMed] [Google Scholar]
  3. Engbersen A. M., Franken D. G., Boers G. H., Stevens E. M., Trijbels F. J., Blom H. J. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet. 1995 Jan;56(1):142–150. [PMC free article] [PubMed] [Google Scholar]
  4. Frosst P., Blom H. J., Milos R., Goyette P., Sheppard C. A., Matthews R. G., Boers G. J., den Heijer M., Kluijtmans L. A., van den Heuvel L. P. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995 May;10(1):111–113. doi: 10.1038/ng0595-111. [DOI] [PubMed] [Google Scholar]
  5. Kang S. S., Zhou J., Wong P. W., Kowalisyn J., Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet. 1988 Oct;43(4):414–421. [PMC free article] [PubMed] [Google Scholar]
  6. Kirke P. N., Molloy A. M., Daly L. E., Burke H., Weir D. G., Scott J. M. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med. 1993 Nov;86(11):703–708. [PubMed] [Google Scholar]
  7. Malinow M. R., Nieto F. J., Kruger W. D., Duell P. B., Hess D. L., Gluckman R. A., Block P. C., Holzgang C. R., Anderson P. H., Seltzer D. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol. 1997 Jun;17(6):1157–1162. doi: 10.1161/01.atv.17.6.1157. [DOI] [PubMed] [Google Scholar]
  8. Mills J. L., McPartlin J. M., Kirke P. N., Lee Y. J., Conley M. R., Weir D. G., Scott J. M. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet. 1995 Jan 21;345(8943):149–151. doi: 10.1016/s0140-6736(95)90165-5. [DOI] [PubMed] [Google Scholar]
  9. Molloy A. M., Daly S., Mills J. L., Kirke P. N., Whitehead A. S., Ramsbottom D., Conley M. R., Weir D. G., Scott J. M. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet. 1997 May 31;349(9065):1591–1593. doi: 10.1016/S0140-6736(96)12049-3. [DOI] [PubMed] [Google Scholar]
  10. Molloy A. M., Mills J. L., Kirke P. N., Whitehead A. S., Weir D. G., Scott J. M. Whole-blood folate values in subjects with different methylenetetrahydrofolate reductase genotypes: differences between the radioassay and microbiological assays. Clin Chem. 1998 Jan;44(1):186–188. [PubMed] [Google Scholar]
  11. Ramsbottom D., Scott J. M., Molloy A., Weir D. G., Kirke P. N., Mills J. L., Gallagher P. M., Whitehead A. S. Are common mutations of cystathionine beta-synthase involved in the aetiology of neural tube defects? Clin Genet. 1997 Jan;51(1):39–42. doi: 10.1111/j.1399-0004.1997.tb02412.x. [DOI] [PubMed] [Google Scholar]
  12. Steegers-Theunissen R. P., Boers G. H., Trijbels F. J., Finkelstein J. D., Blom H. J., Thomas C. M., Borm G. F., Wouters M. G., Eskes T. K. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism. 1994 Dec;43(12):1475–1480. doi: 10.1016/0026-0495(94)90004-3. [DOI] [PubMed] [Google Scholar]
  13. Viel A., Dall'Agnese L., Simone F., Canzonieri V., Capozzi E., Visentin M. C., Valle R., Boiocchi M. Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas. Br J Cancer. 1997;75(8):1105–1110. doi: 10.1038/bjc.1997.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Whitehead A. S., Gallagher P., Mills J. L., Kirke P. N., Burke H., Molloy A. M., Weir D. G., Shields D. C., Scott J. M. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM. 1995 Nov;88(11):763–766. [PubMed] [Google Scholar]
  15. den Heijer M., Blom H. J., Gerrits W. B., Rosendaal F. R., Haak H. L., Wijermans P. W., Bos G. M. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet. 1995 Apr 8;345(8954):882–885. doi: 10.1016/s0140-6736(95)90008-x. [DOI] [PubMed] [Google Scholar]
  16. te Poele-Pothoff M. T., van den Berg M., Franken D. G., Boers G. H., Jakobs C., de Kroon I. F., Eskes T. K., Trijbels J. M., Blom H. J. Three different methods for the determination of total homocysteine in plasma. Ann Clin Biochem. 1995 Mar;32(Pt 2):218–220. doi: 10.1177/000456329503200218. [DOI] [PubMed] [Google Scholar]
  17. van der Put N. M., Eskes T. K., Blom H. J. Is the common 677C-->T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. QJM. 1997 Feb;90(2):111–115. doi: 10.1093/qjmed/90.2.111. [DOI] [PubMed] [Google Scholar]
  18. van der Put N. M., Steegers-Theunissen R. P., Frosst P., Trijbels F. J., Eskes T. K., van den Heuvel L. P., Mariman E. C., den Heyer M., Rozen R., Blom H. J. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 1995 Oct 21;346(8982):1070–1071. doi: 10.1016/s0140-6736(95)91743-8. [DOI] [PubMed] [Google Scholar]
  19. van der Put N. M., Thomas C. M., Eskes T. K., Trijbels F. J., Steegers-Theunissen R. P., Mariman E. C., De Graaf-Hess A., Smeitink J. A., Blom H. J. Altered folate and vitamin B12 metabolism in families with spina bifida offspring. QJM. 1997 Aug;90(8):505–510. doi: 10.1093/qjmed/90.8.505. [DOI] [PubMed] [Google Scholar]
  20. van der Put N. M., van den Heuvel L. P., Steegers-Theunissen R. P., Trijbels F. J., Eskes T. K., Mariman E. C., den Heyer M., Blom H. J. Decreased methylene tetrahydrofolate reductase activity due to the 677C-->T mutation in families with spina bifida offspring. J Mol Med (Berl) 1996 Nov;74(11):691–694. doi: 10.1007/s001090050073. [DOI] [PubMed] [Google Scholar]
  21. van der Put N. M., van der Molen E. F., Kluijtmans L. A., Heil S. G., Trijbels J. M., Eskes T. K., Van Oppenraaij-Emmerzaal D., Banerjee R., Blom H. J. Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. QJM. 1997 Aug;90(8):511–517. doi: 10.1093/qjmed/90.8.511. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES